- Learn More
Paul, Weiss is widely recognized as having one of the nation’s preeminent securities litigation and regulatory practices. For two decades, our lawyers have guided global corporations and financial institutions through a series of “bet-the-company” securities-related crises, consistently reducing or eliminating their most damaging claims and negotiating favorable resolutions.
Litigation partner Dan Kramer was recognized as a “Litigation Trailblazer” by The National Law Journal. Dan was recognized for his representation of Merck in a large class action involving the cholesterol drug Vytorin, and his representation of AIG in connection with its 2005 financial restatement and the exit of CEO Hank Greenberg.